{"id":10516,"date":"2025-12-15T21:56:12","date_gmt":"2025-12-15T20:56:12","guid":{"rendered":"https:\/\/www.hartwigmedicalfoundation.nl\/?p=10516"},"modified":"2025-12-16T18:08:10","modified_gmt":"2025-12-16T17:08:10","slug":"large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/","title":{"rendered":"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>A recent publication in <a href=\"https:\/\/cambridgebrc.nihr.ac.uk\/2025\/10\/08\/clinical-potential-of-whole-genome-data-linked-to-mortality-statistics-in-patients-with-breast-cancer-in-the-uk-a-retrospective-analysis\/\"><em>The Lancet Oncology<\/em><\/a> (October 7, 2025) shows that Whole Genome Sequencing (WGS) is ready for large-scale use in clinical practice. Thanks to advances in technology, logistics, and data infrastructure, WGS is rapidly evolving into a triage tool: a single test that maps all genetic drivers, structural variations, and predictive markers.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWGS provides a complete and integrated genetic profile for each patient\u2014capturing all driver mutations, mutational signatures, and prognostic biomarkers in a single analysis,\u201d the researchers noted.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The research team, led by Prof. Dr. Serena Nik-Zainal (University of Cambridge), analyzed nearly 2,500 breast cancer patients from the 100,000 Genomes Project cohort. According to the authors, this is the largest population-based WGS study in breast cancer conducted to date. By linking whole-genome data to national mortality statistics, they were able to show that WGS is not only diagnostically valuable, but also prognostically and therapeutically informative.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/12\/1-1024x1024.png\" alt=\"\" class=\"wp-image-10524\" style=\"width:553px;height:auto\" srcset=\"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/12\/1-1024x1024.png 1024w, https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/12\/1-300x300.png 300w, https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/12\/1-150x150.png 150w, https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/12\/1-768x768.png 768w, https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/12\/1.png 1080w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Key Findings<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><strong>Clinical relevance in 27% of tumors<\/strong><\/strong>&nbsp;<br>In more than a quarter of tumors, genetic features with direct or potential clinical importance were&nbsp;identified, such as homologous recombination deficiency (HRD), mutations associated with therapy resistance, and signatures&nbsp;indicating&nbsp;sensitivity to targeted treatments. \u201cWe report personalized genomic information in 27% of breast cancers, representing potential clinical impact for more than 15,000 patients per year in the United Kingdom.\u201d&nbsp;<\/li>\n\n\n\n<li><strong><strong>Predictive value for survival<\/strong><\/strong>&nbsp;<br>Genomic data proved to be strong, independent predictors of survival\u2014complementing classical factors such as age, stage, and tumor grade.&nbsp;<\/li>\n\n\n\n<li><strong><strong>New genomic risk framework for ER-positive, HER2-negative breast cancer<\/strong><\/strong>&nbsp;<br>The researchers developed a model that allows for more&nbsp;accurate&nbsp;patient stratification:&nbsp;\n<ul class=\"wp-block-list\">\n<li><strong>Low clinical but high genomic risk<\/strong>&nbsp;\u2013 calls for more intensive treatment or follow-up<\/li>\n\n\n\n<li><strong>Low risk&nbsp;on both levels<\/strong>&nbsp;\u2013 may support treatment de-escalation<\/li>\n\n\n\n<li><strong>High risk&nbsp;without targeted options<\/strong>&nbsp;\u2013 focus on new therapeutic strategies&nbsp;<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>WGS as a new triage tool<br><\/strong>Because WGS provides a complete overview of all genetic abnormalities, the researchers argue for a shift in mindset: use the genome as the starting point for care, rather than an add-on. \u201cWe present a blueprint for using WGS as a triage instrument in clinical care and for enrolling patients in breast cancer trials. In this way, WGS can serve as the first integrated step in diagnosis, treatment, and trial selection.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Importance of Data and Infrastructure<br><\/strong>The findings align with earlier research based on the Hartwig Medical Foundation database (<a href=\"https:\/\/www.nature.com\/articles\/s41588-019-0507-7\"><em>Nature Genetics<\/em><\/a>, 2019), which demonstrated the actionability of WGS in metastatic breast cancer.<br>The new analysis in <em>The Lancet Oncology<\/em> goes a step further: by linking WGS to survival data and developing a predictive model, the translation to clinical practice becomes even more concrete.<br>This progress is largely enabled by national initiatives such as the 100,000 Genomes Project and the NHS Genomic Medicine Service, which collect large-scale genome and outcome data in an integrated way. Without such datasets, it would not have been possible to demonstrate robust associations between genomic profiles and survival\u2014highlighting the value of data-driven oncology research.<br>Hartwig, together with hospitals and organizations including HealthRI and IKNL, aims to establish a comparable infrastructure in the Netherlands.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>More Information<\/strong>&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.hartwigmedicalfoundation.nl\/en\/data\/research-and-science\/scientific-publications\/\" target=\"_blank\" rel=\"noreferrer noopener\">All publications based on data from the Hartwig Medical database<\/a>&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A recent publication in The Lancet Oncology (October 7, 2025) shows that Whole Genome Sequencing (WGS) is ready for large-scale &hellip;<\/p>\n","protected":false},"author":13,"featured_media":9482,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[85,76,73,82,77],"tags":[],"class_list":["post-10516","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-learning-healthcare-system","category-molecular-diagnostics","category-personalized-treatment","category-research","category-scientific-publications"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer - Hartwig Medical Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer - Hartwig Medical Foundation\" \/>\n<meta property=\"og:description\" content=\"A recent publication in The Lancet Oncology (October 7, 2025) shows that Whole Genome Sequencing (WGS) is ready for large-scale &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Hartwig Medical Foundation\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-15T20:56:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-16T17:08:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/04\/DSF5029.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Evan Handgraaf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Evan Handgraaf\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/\"},\"author\":{\"name\":\"Evan Handgraaf\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#\\\/schema\\\/person\\\/f0504804b74eb53ec75c88a420ab41ec\"},\"headline\":\"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer\",\"datePublished\":\"2025-12-15T20:56:12+00:00\",\"dateModified\":\"2025-12-16T17:08:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/\"},\"wordCount\":542,\"image\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DSF5029.jpg\",\"articleSection\":[\"Learning healthcare system\",\"Molecular diagnostics\",\"Personalized treatment\",\"Research\",\"Scientific publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/\",\"name\":\"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer - Hartwig Medical Foundation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DSF5029.jpg\",\"datePublished\":\"2025-12-15T20:56:12+00:00\",\"dateModified\":\"2025-12-16T17:08:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#\\\/schema\\\/person\\\/f0504804b74eb53ec75c88a420ab41ec\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DSF5029.jpg\",\"contentUrl\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/DSF5029.jpg\",\"width\":1440,\"height\":1080},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#website\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/\",\"name\":\"Hartwig Medical Foundation\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/#\\\/schema\\\/person\\\/f0504804b74eb53ec75c88a420ab41ec\",\"name\":\"Evan Handgraaf\",\"url\":\"https:\\\/\\\/www.hartwigmedicalfoundation.nl\\\/en\\\/author\\\/evan-handgraaf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer - Hartwig Medical Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer - Hartwig Medical Foundation","og_description":"A recent publication in The Lancet Oncology (October 7, 2025) shows that Whole Genome Sequencing (WGS) is ready for large-scale &hellip;","og_url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/","og_site_name":"Hartwig Medical Foundation","article_published_time":"2025-12-15T20:56:12+00:00","article_modified_time":"2025-12-16T17:08:10+00:00","og_image":[{"width":1440,"height":1080,"url":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/04\/DSF5029.jpg","type":"image\/jpeg"}],"author":"Evan Handgraaf","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Evan Handgraaf","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/"},"author":{"name":"Evan Handgraaf","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#\/schema\/person\/f0504804b74eb53ec75c88a420ab41ec"},"headline":"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer","datePublished":"2025-12-15T20:56:12+00:00","dateModified":"2025-12-16T17:08:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/"},"wordCount":542,"image":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/04\/DSF5029.jpg","articleSection":["Learning healthcare system","Molecular diagnostics","Personalized treatment","Research","Scientific publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/","url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/","name":"Large-Scale UK study confirms clinical value of Whole Genome Sequencing in breast cancer - Hartwig Medical Foundation","isPartOf":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/04\/DSF5029.jpg","datePublished":"2025-12-15T20:56:12+00:00","dateModified":"2025-12-16T17:08:10+00:00","author":{"@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#\/schema\/person\/f0504804b74eb53ec75c88a420ab41ec"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/large-scale-uk-study-confirms-clinical-value-of-whole-genome-sequencing-in-breast-cancer\/#primaryimage","url":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/04\/DSF5029.jpg","contentUrl":"https:\/\/www.hartwigmedicalfoundation.nl\/wp-content\/uploads\/2025\/04\/DSF5029.jpg","width":1440,"height":1080},{"@type":"WebSite","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#website","url":"https:\/\/www.hartwigmedicalfoundation.nl\/","name":"Hartwig Medical Foundation","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hartwigmedicalfoundation.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.hartwigmedicalfoundation.nl\/#\/schema\/person\/f0504804b74eb53ec75c88a420ab41ec","name":"Evan Handgraaf","url":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/author\/evan-handgraaf\/"}]}},"_links":{"self":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts\/10516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/comments?post=10516"}],"version-history":[{"count":2,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts\/10516\/revisions"}],"predecessor-version":[{"id":10527,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/posts\/10516\/revisions\/10527"}],"wp:attachment":[{"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/media?parent=10516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/categories?post=10516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hartwigmedicalfoundation.nl\/en\/wp-json\/wp\/v2\/tags?post=10516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}